NeoGenomics, Inc. (NEO)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 13.92 |
| Open | 14.00 |
| Bid | 13.94 x 200 |
| Ask | 14.00 x 100 |
| Day's Range | 13.51 - 14.36 |
| 52 Week Range | 11.03 - 21.22 |
| Volume | |
| Avg. Volume | 945,824 |
| Market Cap | 1.783B |
| Beta (5Y Monthly) | 1.10 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.66 |
| Earnings Date | Apr 30, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.73 |
- GuruFocus.com
NeoGenomics Inc (NEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
Discover how NeoGenomics is navigating market dynamics with robust revenue growth and strategic expansions in clinical diagnostics.
ZacksHere's What Key Metrics Tell Us About NeoGenomics (NEO) Q1 Earnings
While the top- and bottom-line numbers for NeoGenomics (NEO) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
GuruFocus.comNeoGenomics Q1 2024 Earnings: Revenue Surpasses Estimates, Net Loss Narrows
Insight into NeoGenomics' Financial Performance and Future Outlook
© 2024 Yahoo. All rights reserved.